NXGN — Nextgen Healthcare Balance Sheet
0.000.00%
TechnologyBalancedMid Cap
- $1.61bn
- $1.67bn
- $653.17m
Annual balance sheet for Nextgen Healthcare, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 33.1 | 138 | 73.3 | 59.8 | 238 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 104 | 93.4 | 97.8 | 108 | 113 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 160 | 260 | 208 | 212 | 402 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 21.4 | 50.8 | 33 | 20.4 | 9.76 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 533 | 720 | 644 | 628 | 896 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 128 | 143 | 181 | 181 | 198 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 157 | 320 | 213 | 205 | 496 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 376 | 400 | 432 | 423 | 400 |
| Total Liabilities & Shareholders' Equity | 533 | 720 | 644 | 628 | 896 |
| Total Common Shares Outstanding |